Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.36 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.36 |
| ▸ | CA2 | P00918 | 2/20 | 0.35 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.33 |
| ▸ | ESR1 | P03372 | 1/20 | 0.33 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.33 |
| ▸ | GRIN2A | Q12879 | 1/20 | 0.31 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL811000 | 1.00 | HSP90AA1 (0.36) | HSP90AA1KCNH2CA2NR1H2LMNA | |
| SCHEMBL21219435 | 0.89 | ALDH1A1 (0.34) | CA2 | |
| SCHEMBL8484616 | 0.83 | ALDH1A1 (0.48) | LMNA | |
| SCHEMBL12817964 | 0.80 | — | — | |
| SCHEMBL4418190 | 0.76 | THRA (0.44) | HSP90AA1KCNH2CA2 | |
| SCHEMBL4414910 | 0.76 | THRA (0.44) | HSP90AA1KCNH2CA2 | |
| SCHEMBL8770515 | 0.74 | — | — | |
| SCHEMBL7156898 | 0.74 | ESR1 (0.46) | CA2LMNAESR1ESR2 | |
| SCHEMBL9146595 | 0.71 | LTA4H (0.43) | LMNAESR1ESR2 | |
| SCHEMBL10407904 | 0.71 | NR1H2 (0.55) | HSP90AA1KCNH2CA2NR1H2LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8785123-B2 | Direct hierarchical assembly of nanoparticles | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2014-07-22 | — | — | US | claimed |
| US-20120309904-A1 | Direct Hierarchical Assembly of Nanoparticles | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2012-12-06 | — | — | US | claimed |
| WO-2011047386-A1 | DIRECT HIERARCHICAL ASSEMBLY OF NANOPARTICLES | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2011-04-21 | — | — | WO | claimed |
| US-20250110101-A1 | PER AND POLYFLUOROALKYL SUBSTANCE MEASUREMENT | DEXSIL CORPORATION (US) | 2025-04-03 | — | — | US | disclosed |
| US-20240059860-A1 | METHODS AND SYSTEMS FOR DESTRUCTION OF SYNTHETIC PER- AND POLYFLUORO COMPOUNDS | CHZ TECHNOLOGIES, LLC | 2024-02-22 | — | — | US | disclosed |
| US-8785123-B2 | Direct hierarchical assembly of nanoparticles | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2014-07-22 | — | — | US | disclosed |
| US-20120309904-A1 | Direct Hierarchical Assembly of Nanoparticles | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2012-12-06 | — | — | US | disclosed |
| EP-2389399-A2 | FUNCTIONALIZED POLYURETHANE RESIN, METHOD FOR THE PRODUCTION THEREOF, AND USE THEREOF | Construction Research & Technology GmbH (DE) | 2011-11-30 | — | — | EP | disclosed |
| US-20110256438-A1 | WOUND-TYPE ACCUMULATOR | JM ENERGY CORPORATION (JP) | 2011-10-20 | — | — | US | disclosed |
| WO-2011047386-A1 | DIRECT HIERARCHICAL ASSEMBLY OF NANOPARTICLES | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2011-04-21 | — | — | WO | disclosed |
| US-20100324205-A1 | FLUID, FLUORINE-CONTAINING AND SINGLE-COMPONENT COMPOSITION | CONSTRUCTION RESEARCH & TECHNOLOGY GMBH (DE) | 2010-12-23 | — | — | US | disclosed |
| WO-2008040428-A2 | FUNCTIONALIZED POLYURETHANE RESIN, METHOD FOR THE PRODUCTION THEREOF, AND USE THEREOF | CONSTRUCTION RESEARCH & TECHNOLOGY GMBH (DE) | 2008-04-10 | — | — | WO | disclosed |
| US-20060128957-A1 | Fluorous tagging and scavenging reactants and methods of synthesis and use thereof | FLUOROUS TECHNOLOGIES INCORPORATED | 2006-06-15 | — | — | US | disclosed |
| US-7060850-B2 | Fluorous tagging and scavenging reactants and methods of synthesis and use thereof | FLUOROUS TECHNOLOGIES INCORPORATED (US) | 2006-06-13 | — | — | US | disclosed |
| US-20040073054-A1 | New fluorous tagging and scavenging reactants and methods of synthesis and use thereof | FLUOROUS TECHNOLOGIES, INC. | 2004-04-15 | — | — | US | disclosed |
| EP-0468531-B2 | 2-Diazo-1,2-quinone compounds and image forming materials prepared using the compounds | FUJI PHOTO FILM CO LTD (JP) | 1997-11-12 | — | — | EP | disclosed |
| US-5514518-A | CHANGE IN POLARITY UPON EXPOSURE REDUCES ADHESIVENESS | FUJI PHOTO FILM CO., LTD. (JP) | 1996-05-07 | — | — | US | disclosed |
| US-5384227-A | Optical recording material with supports and light sensitive layers, for receiver sheets, photoresists and printing plates | FUJI PHOTO FILM CO., LTD. (JP) | 1995-01-24 | — | — | US | disclosed |
| US-5312905-A | Image forming materials | FUJI PHOTO FILM CO., LTD. (JP) | 1994-05-17 | — | — | US | disclosed |
| EP-0468531-A1 | 2-Diazo-1,2-quinone compounds and image forming materials prepared using the compounds | FUJI PHOTO FILM CO., LTD. (JP) | 1992-01-29 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040073054-A1 | New fluorous tagging and scavenging reactants and methods of synthesis and use thereof | THEM6, NOTUM, RNF31 | HSP90AA1 4545/4885KCNH2 4554/4885CA2 3304/4885 |
| US-20060128957-A1 | Fluorous tagging and scavenging reactants and methods of synthesis and use thereof | PFAS, CTSF, AFF2 | HSP90AA1 4463/4885KCNH2 4514/4885CA2 3196/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.